Dtsch Med Wochenschr 2015; 140(11): 782
DOI: 10.1055/s-0041-102289
Leserbrief
© Georg Thieme Verlag KG Stuttgart · New York

Individueller Heilversuch: Roflumilast als Anorektikum

Compassionate use: roflumilast as an anorectic drug
Peter Pommer
1   Abteilung für Pneumologie, Gesundheitszentrum Oberammergau
› Author Affiliations
Further Information

Publication History

Publication Date:
28 May 2015 (online)

 
  • Literatur

  • 1 Blüher M. Konservative Therapie der Adipositas – wann und wie?. Dtsch med Wochenschr 2015; 140: 24-28
  • 2 Wouters EF, Bredenbröker D, Teichmann P et al. Effect of the phosphodiesterase 4 inhibitor roflumilast on glucose metabolism in patients with treatment-naive, newly diagnosed type 2 diabetes mellitus. J Clin Endocrinol Metab 2012; 97: E1720-E1725
  • 3 Vollert S, Kaessner N, Heuser A et al. The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db/db mice. Diabetologia 2012; 55: 2779-2788